KCM
DXCM icon

KRS Capital Management’s DexCom DXCM Stock Holding History

KRS Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,402
Closed -$386K – 118
2024
Q2 		$386K Buy
3,402
+722
+27% +$91.3K 0.29% 74
2024
Q1 		$372K Buy
2,680
+280
+12% +$35.2K 0.3% 78
2023
Q4 		$298K Hold
2,400
– – 0.28% 86
2023
Q3 		$224K Hold
2,400
– – 0.24% 105
2023
Q2 		$308K Hold
2,400
– – 0.31% 87
2023
Q1 		$279K Hold
2,400
– – 0.31% 88
2022
Q4 		$272K Buy
+2,400
New +$263K 0.37% 87
2022
Q2 		– Sell
-2,400
Closed -$306K – 101
2022
Q1 		$306K Hold
2,400
– – 0.33% 87
2021
Q4 		$322K Buy
+2,400
New +$345K 0.28% 84

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

KRS Capital Management's DXCM Position: Q3 2024 in Review

KRS Capital Management sold out of DexCom (DXCM) in Q3 2024, closing a stake of 3,402 shares — an estimated $386K sold.

KRS Capital Management first reported a position in DXCM in Q4 2021 and held it in 9 quarters. The position peaked at $386K in Q2 2024. 890 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • KRS Capital Management reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • KRS Capital Management sold 3,402 DexCom shares in Q3 2024, an estimated $386K.
  • KRS Capital Management first reported a position in DexCom in Q4 2021 and held it in 9 quarters.
  • KRS Capital Management's DexCom position peaked at $386K in Q2 2024.
  • 890 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on KRS Capital Management's 13F filing for Q3 2024, filed 15 Oct 2024.